Subscribe By E-Mail

AVI BioPharma Receives NASDAQ Notice of Minimum Bid Price Non-Compliance – MarketWatch (press release)

AVI BioPharma Receives NASDAQ Notice of Minimum Bid Price Non-Compliance
MarketWatch (press release)
If at any time before this date AVI's common stock has a closing bid price of $ 1.00 or more for a minimum of 10 consecutive business days, NASDAQ staff will notify AVI that it has regained compliance. If AVI cannot demonstrate compliance with Rule
Shares of AVI BioPharma Have Fallen Below Previous 52-Week LowFinancial News Network Online

all 18 news articles »

nasdaq – Google News